Botanisol Analytics Performs Validation Process of Rapid Digital COVID-19 Screener with Leading Hospital

Autor:	PR Newswire
Zdroj:	PR Newswire US. 02/24/2021.
Abstrakt:	BOSTON, Feb. 24, 2021 /PRNewswire-PRWeb/ -- Botanisol Analytics, a cutting-edge biological threat detection technology company, is performing, under a sponsored research agreement, a pre-clinical study with Beth Israel Deaconess Medical Center (BIDMC), an academic medical center affiliated with Harvard Medical School (HMS), that was designed to validate its rapid digital pathogen screening system for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.